PRESS RELEASE published on 03/26/2026 at 07:45, 2 months 26 days ago Eckert & Ziegler: Strong FY 2025 with Positive Outlook Eckert & Ziegler SE achieved strong performance in FY 2025 with sales of €312.0 million and plans for approx. €320 million sales in 2026, alongside an adjusted EBIT of approx. €80 million Sales Growth Forecast Earnings Increase Eckert & Ziegler SE FY 2025
BRIEF published on 03/06/2026 at 10:41, 3 months 15 days ago Eckert & Ziegler propose un dividende de 0,22 € par action pour 2025 Assemblée Générale Annuelle Relations Avec Les Investisseurs Proposition De Dividende Exercice Financier 2025 Eckert Et Ziegler
BRIEF published on 03/06/2026 at 10:41, 3 months 15 days ago Eckert & Ziegler Proposes €0.22 Dividend per Share for 2025 Annual General Meeting Investor Relations Eckert & Ziegler Dividend Proposal Financial Year 2025
PRESS RELEASE published on 03/06/2026 at 10:36, 3 months 15 days ago EQS-Adhoc: Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025 Eckert & Ziegler SE plans dividend of €0.22 per share for 2025, subject to AGM approval. Detailed financial statements to be released on March 26, 2026 Shareholders Annual Financial Statements Dividend Eckert & Ziegler SE 2025 Financial Year
BRIEF published on 02/26/2026 at 07:05, 3 months 23 days ago Eckert & Ziegler Partners with Molecular Partners for Radio-DARPin Development Partnership Cancer Treatment Eckert & Ziegler Radiopharmaceuticals Radio-DARPin
BRIEF published on 02/26/2026 at 07:05, 3 months 23 days ago Eckert & Ziegler s'associe à Molecular Partners pour le développement de Radio-DARPin Partenariat Traitement Du Cancer Produits Radiopharmaceutiques Eckert Et Ziegler Radio-DARPin
PRESS RELEASE published on 02/26/2026 at 07:00, 3 months 23 days ago Eckert & Ziegler Enters Partnership with Molecular Partners to Support Development of Radio-DARPin Therapeutics Eckert & Ziegler SE partners with Molecular Partners to develop Radio-DARPin therapeutics, leveraging DARPin technology for cancer treatment with alpha emitters Partnership Eckert & Ziegler Therapeutics Radio-DARPin Molecular Partners
BRIEF published on 02/16/2026 at 11:05, 4 months 5 days ago Eckert & Ziegler and UJF Boost Actinium-225 Production Eckert & Ziegler Radiopharmaceuticals Production Increase Actinium-225 Global Supply
BRIEF published on 02/16/2026 at 11:05, 4 months 5 days ago Eckert & Ziegler et l'UJF stimulent la production d'actinium-225 Produits Radiopharmaceutiques Augmentation De La Production Actinium-225 Approvisionnement Mondial Eckert Et Ziegler
PRESS RELEASE published on 02/16/2026 at 11:00, 4 months 5 days ago Eckert & Ziegler and UJF Significantly Increase Production Volume for Actinium-225 Eckert & Ziegler SE and UJF increase Actinium-225 production volume, addressing global demand for alpha-emitting radionuclides in targeted radiopharmaceutical applications Eckert & Ziegler Production Volume Radiopharmaceuticals Actinium-225 UJF
Published on 06/20/2026 at 01:00, 2 days 3 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 4 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 23 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 2 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/20/2026 at 21:25, 1 day 6 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 22 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 7 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 7 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 2 days 8 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 2 days 8 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 8 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 8 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 8 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
